Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder and the most common type of dementia (60–80% of cases). In 2016, nearly 44 million people were affected by AD or related dementia. AD is characterized by progressive neuronal damages leading to subtle and latter obvious decline in...
Main Authors: | Cyril Laurent, Luc Buée, David Blum |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-02-01
|
Series: | Biomedical Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S231941701730313X |
Similar Items
-
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
by: Goran Šimić, et al.
Published: (2016-01-01) -
Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
by: Jakub Sinsky, et al.
Published: (2021-08-01) -
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
by: Pankajavalli Ramakrishnan, et al.
Published: (2003-11-01) -
Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
by: Kovacech Branislav, et al.
Published: (2010-10-01) -
The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
by: Rafaella Araujo Gonçalves, et al.
Published: (2019-02-01)